期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
The application of renal sympathetic denervation in cardiovascular and other diseases
1
作者 邢海珊 王大英 +2 位作者 刘宗军 张颖 袁航 《South China Journal of Cardiology》 CAS 2024年第1期57-66,F0003,共11页
Background The role of renal artery sympathetic nerve ablation,widely known as renal sympathetic denervation(RDN)in the treatment of resistant hypertension(RH)has been clarified,and there is more and more evidence to ... Background The role of renal artery sympathetic nerve ablation,widely known as renal sympathetic denervation(RDN)in the treatment of resistant hypertension(RH)has been clarified,and there is more and more evidence to support its effect in the treatment of heart failure,ventricular hypertrophy and arteriosclerosis.Some studies also reported its role in treatment related to respiratory system(pulmonary hypertension,sleep apnea syndrome),endocrine system(metabolic syndrome,blood lipid metabolism,polycystic ovary syndrome),kidney disease(acute renal injury,renal failure)and other inflammation,remodeling,pain and so on.Though most of them were subgroup analysis and small-sample studies,even case reports,they had shed some light on possible use of RDN in the treatment of multi-system diseases.[S Chin J Cardiol 2024;25(1):57-66]. 展开更多
关键词 renal artery sympathetic nerve ablation Respiratory disease ENDOCRINE KIDNEY
原文传递
Main Renal Artery Plus Branch Ablation in the Treatment of Resistant Hypertension with Renal Denervation
2
作者 Tian-Jiao Lyu Ling-Yan Li +3 位作者 Xu Wang Jian Ye Jun-Qing Gao Zong-Jun Liu 《Cardiovascular Innovations and Applications》 2021年第4期91-98,共8页
Objective:To study the safety and effi cacy of denervation of renal artery branches in the treatment of resistant hy-pertension.Methods:Sixty patients with resistant hypertension were enrolled.The patients were random... Objective:To study the safety and effi cacy of denervation of renal artery branches in the treatment of resistant hy-pertension.Methods:Sixty patients with resistant hypertension were enrolled.The patients were randomly assigned to the main renal artery plus branch ablation group or the main renal artery ablation group.The clinical data and operation-related parameters,including number of ablation points,temperature,and average energy,were recorded.Ambulatory blood pressure was taken for all patients at the baseline and at 6 months after treatment.Offi ce blood pressure was recorded before treatment and after treatment every 3 months for 2 years.Results:Sixty patients with resistant hypertension were enrolled in this study.There were 30 patients in each group.Angiography was performed after ablation.No renal artery complications,such as stenosis and dissection,occurred in the two groups.There was no signifi cant difference in age,sex,BMI,comorbid disease,and medication between the two groups(P>0.05).The number of ablation points for the main renal artery plus branch ablation group was greater than that for the main renal artery ablation group.The offi ce blood pressure and 24-hour blood pressure were signifi cantly lower 6 months after treatment than before treatment in both groups(P<0.05).Offi ce blood pressure in the main renal artery plus branch ablation group was lower than that in the main renal artery ablation group during the 3-12-month follow-up period,with a statistical difference.However,as the follow-up time increased,the difference disappeared.Conclusion:The results of this study show that main renal artery plus branch ablation is a safe interventional method,but there was no obvious advantage on long-term follow-up compared with only main renal artery ablation. 展开更多
关键词 renal denervation resistant hypertension percutaneous renal artery sympathetic nerve ablation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部